WASHINGTON (ChurchMilitant.com) - A contingent of congressmen is petitioning the Food and Drug Administration (FDA) to ban the abortion drug RU486.
Senator Ted Cruz of Texas, along with 19 GOP Senate colleagues and 71 House Republicans, sent a letter to the FDA Tuesday, requesting the ban of Mifeprex. This is the drug commonly known as RU486, which kills preborn children up to 10 weeks after their conception.
The letter, addressed to FDA Commissioner Stephen Hahn, calls out the nefarious agenda of the Culture of Death to deregulate abortion: "It is by now nakedly obvious that the abortion industry and its allies in the media, billionaire philanthropic circles and special interest groups have wanted an unregulated and de-medicalized abortion pill since the moment the FDA first approved it in 2000."
The letter purports that the federal government under the Clinton administration approved this deadly drug under intense pressure.
Clinton, the nation's first blatantly pro-abortion president, was under pressure from the cultural Left to move on the initiative to legalize RU486.
"As you may further know, the Clinton administration approved this lethal drug under pressure from these same groups and under a highly politicized approval process," the letter asserted.
A brief history of the abortion drug shows that researchers at French pharmaceutical company Roussel Uclaf developed the drug in 1980. Trials were conducted beginning in 1983. In the late 1980s, the French legalized the deadly drug. Although the senior Bush administration in the United States banned the import of the drug from France, President Clinton in 1993 asked the FDA to re-examine that ban.
In 1996, the FDA approved as safe and effective the use of RU486. At the Clinton administration's behest, it was finally approved in the United States in 2000.
"We believe this deadly pill should never have been approved," the letter contended, yet the abortion industry was politically rewarded with an accelerated approval process normally reserved for high-risk drugs that address life-threatening illnesses like AIDS."
The abortion pill does not remedy life-threatening illnesses, the congressmen claim in the letter. In fact, it not only threatens life, but its very purpose is to kill the child within. Cruz and his contingent claim this is not health care at all.
"As you are surely aware, pregnancy is not a life-threatening illness, and the abortion pill does not cure or prevent any disease. Nevertheless, this pill that is specifically designed and intended to kill preborn children was raced to the market, with devastating consequences," they wrote to Hahn.
The congressmen propounded in the letter that the RU486 abortion pill has already been used to murder an estimated 3.7 million unborn babies in America. It has caused 24 maternal deaths and has resulted in more than 4,100 adverse reactions in mothers using the pill.
According to the signers, this includes "hemorrhage, excruciating abdominal pain and severe life-threatening infections."
After claiming that such injuries are greatly underreported, the signers of the letter encouraged Hahn to exercise the FDA's existing authority to declare Mifeprex "an imminent hazard to public health" that poses "a significant threat of danger."
Last month the Trump administration petitioned the Supreme Court to reinstate restrictions on abortion drugs that were suspended due to the Wuhan virus pandemic. This would disable women from buying the deadly drug unless they first visit a medical facility. Acknowledgment in writing of being advised of the drug's serious risks was also mandatory before the lifting of COVID restrictions.
Mallory Quigley, vice president of communications for the pro-life organization Susan B. Anthony List (SBAL), told The Epoch Times Wednesday that "chemical abortion drugs are dangerous and put women at serious risk of heavy bleeding, infection and even death."
SBAL believes Democrat officials place "the profits of the abortion industry over the protection of women and their children."
Loading Comments
Sign up for our newsletter to continue reading